Get started
Author

Patrícia Miguel Semedo

Observed names: P. Semedo, P.M. Semedo, Patricia Miguel Semedo, Patricia Semedo, Patrícia M Semedo
Observed institutions: University of Lisbon, Universidade Católica Portuguesa, Unidade Local de Saúde de São José, Centro Hospitalar Lisboa Norte, Hospital de Santa Maria, Instituto de Medicina Molecular João Lobo Antunes, Unidade Local de Saúde Santa Maria
ORCID: 0000-0002-8984-6832
Observed ORCID: 0000-0002-8984-6832
OpenAlex ID: A5007589525
Implementing a PROACTive Care Pathway to Empower and Support Survivors of Breast Cancer
2023 · Maria Alice Franzoi, Lena Degousée, et al. · JCO Oncology Practice · 23
PDF
Chemoradiotherapy completion and neutropenia risk in HIV patients with cervical cancer
2018 · Ines Vendrell, Arlindo R. Ferreira, et al. · Medicine · 13
Prognostic Factors for Patients Treated With Abiraterone
2019 · Cecília M Alvim, André Mansinho, et al. · Future Science OA · 9
360 Health Analysis (H360)—A Comparison of Key Performance Indicators in Breast Cancer Management across Health Institution Settings in Portugal
2023 · Inês Brandão Rego, Sara Coelho, et al. · Current Oncology · 6
PDF
360 Health Analysis (H360) – A Proposal for an Integrated Vision of Breast Cancer in Portugal
2020 · Instituto Português de Oncologia do Porto Francisco Gentil EPE, Porto, Portugal, Sara Coelho, et al. · European Journal of Breast Health · 3
PDF
Poster Session 3
2011 · G. M. T. Fabbri, S. Baldasseroni, et al. · EP Europace · 3
P-047 Effectiveness of TACE as bridge therapy for liver transplant in hepatocellular carcinoma
2016 · C. Ribeiro, J. Barreira, et al. · Annals of Oncology · 2
The MELimmune score—prognostic factors for overall survival in advanced melanoma and anti-PD-1 monotherapy—a multicentre, retrospective cohort study
2025 · S. Lobo-Martins, D. Martins-Branco, et al. · Immuno-Oncology Technology · 1
Unique Peripheral Immune Profile in Young Women with Metastatic Breast Cancer
2024 · Catarina Abreu, Patricia Corredeira, et al. · Journal of young women's breast cancer and health. · 1
P-65 Locally advanced/metastatic gastric cancer: Real-world data on first-line treatment with oxaliplatin and cisplatin-based doublets
2020 · H. Luna Pais, A. Mansinho, et al. · Annals of Oncology · 1
PDF
112P Defining who benefits: Adjuvant treatment patterns and survival outcomes in stage II colon cancer - A multicenter real-world analysis
2025 · T. Pina-Cabral, S. Lobo-Martins, et al. · Annals of Oncology
PDF
Abstract P1-03-03: Impact of Mainstreaming Protocol in Clinical Practice of Breast Cancer Patients
2025 · João Araújo, Inês Soares de Pinho, et al. · Clinical Cancer Research
271P BRIGHT project: A polygenic-risk approach to breast cancer screening in a Portuguese institution
2025 · J. Araújo, G. Nogueira da Costa, et al. · ESMO Open
PDF
1122P Neutrophil/lymphocyte ratio and systemic inflammatory index as prognostic biomarkers in metastatic melanoma patients under immune checkpoint inhibitors: Could any of them be used?
2023 · M.B. Menezes, L. Goncalves, et al. · Annals of Oncology
PDF
360 Health Analysis (H360) – Quality of Life of Breast Cancer Patients: an Integrated Vision
2023 · Patrícia Miguel Semedo, Sara Coelho, et al. · Archives of Clinical and Biomedical Research
7 Prognostic factors for overall survival in patients with advanced melanoma treated with Anti-PD-1 therapy – the melimmune score
2020 · Soraia Lobo-Martins, Diogo Martins-Branco, et al. · Journal for ImmunoTherapy of Cancer
P-151 The impact of adjuvant chemotherapy regimens in stage II colon cancer (CC) patients
2020 · S. Lobo-Martins, M. Martins, et al. · Annals of Oncology
PO-070 Prognostic value of hyponatremia on metastatic or recurrent head and neck squamous cell carcinoma
2019 · C. Melo Alvim Moreira, P. Semedo, et al. · Radiotherapy and Oncology
Potential prognostic factors for metastatic castration resistant prostate cancer with Abiraterone Acetate
2018 · C. Melo Alvim Moreira, A. Mansinho, et al. · European Urology Supplements
P-102 Sorafenib after locoregional treatments for advanced or recurrent hepatocellular carcinoma
2016 · C. Ribeiro, J. Barreira, et al. · Annals of Oncology
Poster Session 2
2011 · T. Andersson, A. Magnusson, et al. · EP Europace
Poster Session 1
2011 · A. Deshmukh, S. S. Sharma, et al. · EP Europace
2023 POSTER Heparanase expression in circulating lymphocytes of breast cancer patients as a marker of recurence and systemic metastasis
2007 · L.L. de Matos, T.R. Theodoro, et al. · European Journal of Cancer Supplements
A superexpressão da enzima heparanase em células de adenocarcinoma mamário humano(MCF-7) afeta a expressão de glicosaminoglicanos, a proliferação e a adesão celular
2005 · P. Semedo · UNIFESP Institutional Repository (Universidade Federal de São Paulo)
Works count: 25
Citation count: 62
H-index: 4
I10-index: 2
Year
Topic
Type